TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Ligand Pharmaceuticals Inc (NASDAQ: LGND) Investor Securities Class Action Lawsuit 11/17/2016

  • If you purchased shares of Ligand Pharmaceuticals Inc (NASDAQ: LGND), you might have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

May 16, 2017 - The plaintiff filed a notice of voluntary dismissal without prejudice. March 29, 2017 - Lead plaintiff and lead counsel were appointed. January 17, 2017 - Lead plaintiff motions were filed. November 17, 2016 - An investor in shares of Ligand Pharmaceuticals Inc (NASDAQ: LGND) filed a lawsuit in the U.S. District Court for the Southern District of California over all...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: